Consumers are looking for products that deliver specific, evidence-backed health benefits. At SupplySide Global 2026, Clasado Biosciences is highlighting its prebiotic ingredient Bimuno® GOS, which supports innovation across digestive comfort, immune health and mental wellbeing.
As a galactooligosaccharide (GOS), Bimuno GOS is a prebiotic that selectively nourishes beneficial gut bacteria. Backed by more than 135 scientific publications, including over 25 clinical studies, it offers a substantial evidence base for brands developing targeted health products.
Clinical studies of Bimuno GOS have reported improvements in common digestive symptoms, including bloating, abdominal discomfort and flatulence, alongside benefits for bowel regularity. Research has included both healthy adults and individuals experiencing IBS-related symptoms, giving formulators evidence to draw on when developing products for digestive comfort.
The gut microbiome plays a role in immune function, and research is exploring how prebiotics may help support the body under physical stress. In a six-week study involving male athletes, daily supplementation with Bimuno GOS was associated with improved gut barrier integrity, changes in an immune defence marker and shorter, less severe upper respiratory symptom episodes following exercise. The findings highlight Bimuno GOS’s potential in sports nutrition, where maintaining gut comfort and immune health can help support training and performance.
Research into the gut–brain axis is opening new possibilities for prebiotics in mental wellbeing. In healthy adults, Bimuno GOS supplementation was associated with lower waking cortisol levels and improved positive attentional focus. Separate studies have reported reduced anxiety in people with IBS and improvements in cognitive performance in a clinically medicated population. Together, these findings highlight the potential of targeted prebiotics in products addressing stress, mood and cognitive health.
Formulation flexibility
Bimuno GOS has demonstrated a prebiotic effect from just 500 mg of Bimuno GOS per day. Its stability across formats, including gummies, powders and ready-to-drink beverages, also gives developers flexibility when creating products for different needs and preferences.
For brands looking to differentiate their products through clinically researched prebiotic science, Bimuno GOS offers formulation versatility alongside research spanning several areas of health.
Visit booth 4249 at SupplySide Global 2026 to learn more about Bimuno® GOS and its potential applications.
